Hmmm, 3 months late bildo Wednesday, 01/24/18 03:54:41

New Post Public Reply Private Reply Replies (1) Message Board
mikoli007
416
Hmmm, 3 months late
bildo Wednesday, 01/24/18 03:54:41 PM
Re: edwardscott52 post# 84285
Post #
84293
of 84307 Go
"I wonder if MMEX will hit $ 5.13 price by end of October of this year , hmmmmmm. Wouldn't that be just great !!!!! Have a great day everyone."

This is a quote from you early last year. I've been invested here since early summer. I sure hope MMEX builds the refinery. But I'm not sure if I can take you seriously. And I realize that you don't care if I take you serious or not, but come on man. You might be rich, but I'm not. Keep it real.

MMEX Resources Corporation (MMEX) Stock Research Links

MMEX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 0

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 1

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 0

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 2

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Cofactor Genomics Appoints New CEO to Enhance Patient Access

Updated Category News Views 169

Cofactor Genomics Appoints Chris Parker as New CEO Cofactor Genomics, Inc., a commercial-stage company dedicated to bridging the precision medicine gap through RNA decoding, has announced a significant leadership transition. Chris Parker has been appointed as the new CEO and Board Member, succeeding Jarret Glasscock, who will continue his contributions in the roles of...

Continue Reading
Minto Apartment REIT Declares Cash Distribution for July 2025

Updated Category News Views 168

Minto Apartment REIT's Cash Distribution Announcement Minto Apartment Real Estate Investment Trust (MI) has recently made an important announcement regarding its cash distribution. The REIT has declared a monthly cash distribution of $0.04333 per unit for the month of July 2025. This translates to an annualized rate of $0.52 per unit. The payment is set to be distributed...

Continue Reading
National Geographic–Lindblad Expands Alaska Offerings for Travelers

Updated Category News Views 89

Expanding Exploration: National Geographic–Lindblad's New Chapter in Alaska National Geographic–Lindblad Expeditions is celebrating a significant milestone in its quest to enhance adventure travel in Alaska, with plans to expand its offerings starting in 2027. The company is known for its pioneering spirit and leadership in expedition travel, and this expansion is a...

Continue Reading
Brian Krause Takes the Helm as Chief Development Officer at Panera

Updated Category News Views 453

Brian Krause Appointed as Chief Development Officer at Panera Bread Panera Bread, a leader in the fast casual dining sector, has recently announced the appointment of Brian Krause as its new Chief Development Officer. With a wealth of experience in franchise development and strategic growth, Krause aims to propel the company's expansion plans. Krause's Experience and...

Continue Reading
Strategic Growth Ahead for Blockmate Ventures with New Funding

Updated Category News Views 115

Blockmate Ventures Expands Its Horizons with New Investment Blockmate Ventures Inc. (TSX.V: MATE), a company recognized for its innovative approach in the tech world, has recently announced a significant investment commitment of CAD $1,400,000. This strategic funding comes from a group of investors, featuring notable industry figure Antanas Guoga, popularly known as Tony...

Continue Reading